A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.

Ayhan UlusakaryaAbdoulaye KarabouéOriana CiacioGabriella PittauMazen HaydarPamela BiondaniYusuf GumusAmale ChebibWathek AlmohamadPasquale F Innominato

Published in: BMC cancer (2020)

First-line FOLFIRINOX offers promising results in patients with LA and M-BTC. It deserves prospective evaluation to further improve outcomes for advanced BTC.

Keyphrases

locally advanced
rectal cancer
papillary thyroid
squamous cell carcinoma
radiation therapy
case report
squamous cell
smoking cessation
type diabetes
adipose tissue
weight loss